The California Workers’ Compensation Institute reported that a nearly eightfold increase in migraine drug prescriptions coincided with the emergence of several high-cost drugs that are not included in the formulary.
“Although the CWCI study notes that migraine drugs represented only 0.7% of California workers’ compensation prescriptions filled in 2023, that was up from 0.2% in 2018,” the institute said in a statement. “This, along with the ongoing evolution of the migraine drug market and the growing use of several high-cost brand-name drugs for which there are n...
Comments